- Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors. Journal of hematotherapy. 1997 Academic Article GET IT
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia.
Times cited: 44